| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC0778 |
| Trial ID | ChiCTR1800019641 |
| Disease | Hematologic Cancer |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD20 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An open-label, single-center and single-arm clinical study for infusion of anti-CD123 CAR-T cells for patients with relapsed or refractory CD123+ hematological malignancy |
| Year | 2018 |
| Country | China |
| Company sponsor | Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||